Research Article
Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach
Table 3
Odds ratios “OR” (95% CI) for relationships between baseline characteristics of comorbid history/demographic variables/Medicaid group categories and atrial fibrillation status group as an outcome, with cost threshold (of $2000 or more in the year prior to index date or the equivalent for non-AF cases) as a model feature.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Note: 1—The presence of comorbid condition; 0—the absence of comorbid condition; 75–90 (4) vs 18–44 years (0); 65–74 (3) vs 18–44 years (0); 55–64 (2) vs 18–44 years (0); 45–54 (1) vs 18–44 years (0); LTSS—duals (6) vs TANF (0); ABD—duals (5) vs TANF (0); LTSS—nondual (4) vs TANF (0); ABD—nondual (3) vs TANF (0); two groups (2) vs TANF (0); family care (1) vs TANF (0); model feature based on cost threshold of 1 year prior for $2000 or more (1 or > $2000; 0 otherwise); TANF group (1 or > $8750 that is applied for AF cohort only; 0 otherwise); 0—absence of comorbid condition, CL—confidence limits, and C index = 0.822. Data are based on the entire population. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||